The Molecular Cytogenetics Shared Resource (MCSR) provides access to advanced DNA repair and genomic instability analyses to members of the Herbert Irving Comprehensive Cancer Center (HICCC). The services include (1) analyses of chromosomal structural, morphological, and rearrangement patterns (including karyotyping, spectral karyotyping (SKY), chromosome painting, and fluorescence in situ hybridization [FISH]), (2) analyses of genomic instability at specialized genomic regions (telomere, rDNA), (3) DNA damage responses and repair pathway analyses (including the kinetics of DNA repair protein foci), (4) development of genome-wide tools to analyze chromosomal translocation and mutations patterns (including high throughput sequence platforms), and (5) consultation and completed packages for experimental design, staining, data acquisition, and processing. Under the leadership of Shan Zha, PhD, an expert in DNA double-strand breaks repair, these comprehensive and customizable services, together with specialized instruments maintained by the MCSR, enable investigators at varying skill levels with the knowledge to characterize clonal changes as well as non- clonal genomic instability in cancer cells and in premalignant tissues from a wide range of organisms. Over the current project period (2014-2019), MSR has undergone leadership and instrument reorganization. In this process, the MCSR acquired new equipment and developed new assays, which significantly expanded its ability to quantitatively study DNA repair mechanisms. The reorganized MCSR is now managed by a dedicated PhD- level staff and provides convenient, cost-effective, and innovative service to HICCC members. The MCSR provides services that are not available from commercial sources and not easily accessible within the New York metropolitan area and are proven to be critically important to the research of many HICCC members, providing key preliminary data for grant applications and high-impact publications. In addition to providing both basic and advanced services across different area of DNA repair and genomic instability studies, the MCSR also provides training to HICCC members in the operation of specialized instruments and in sample preparation and analyses. In addition, consulting services are available to investigators to assist in the design of the most cost-effective analyses and provide controls needed to validate the assay and the data. The MCSR is committed to incorporating novel experimental portfolios and the use of analytic tools, providing state-of-the-art genomic stability services, and promoting accessibility of services through training and consulting in support of highly collaborative and innovative research ongoing at the HICCC. During the current project period, the MCSR was utilized by 21 HICCC members, supported key data for seven peer-reviewed publications, including four papers in high-impact journals (e.g., Nature, Molecular Cell), and currently supports research for five NIH-funded projects, four from NCI.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA013696-45
Application #
10022772
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-07-04
Project End
2025-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
45
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Jauregui, Ruben; Park, Karen Sophia; Duong, Jimmy K et al. (2018) Quantitative progression of retinitis pigmentosa by optical coherence tomography angiography. Sci Rep 8:13130
O'Neil, Daniel S; Prigerson, Holly G; Mmoledi, Keletso et al. (2018) Informal Caregiver Challenges for Advanced Cancer Patients During End-of-Life Care in Johannesburg, South Africa and Distinctions Based on Place of Death. J Pain Symptom Manage 56:98-106
Liu, Katherine Y; Sengillo, Jesse D; Velez, Gabriel et al. (2018) Missense mutation in SLIT2 associated with congenital myopia, anisometropia, connective tissue abnormalities, and obesity. Orphanet J Rare Dis 13:138
Koch, Susanne F; Tsang, Stephen H (2018) Success of Gene Therapy in Late-Stage Treatment. Adv Exp Med Biol 1074:101-107
DiCarlo, James E; Mahajan, Vinit B; Tsang, Stephen H (2018) Gene therapy and genome surgery in the retina. J Clin Invest 128:2177-2188
Wert, Katherine J; Velez, Gabriel; Cross, Madeline R et al. (2018) Extracellular superoxide dismutase (SOD3) regulates oxidative stress at the vitreoretinal interface. Free Radic Biol Med 124:408-419
Lee, Andreia; CingĂ–z, Oya; Sabo, Yosef et al. (2018) Characterization of interaction between Trim28 and YY1 in silencing proviral DNA of Moloney murine leukemia virus. Virology 516:165-175
Schrank, Benjamin R; Aparicio, Tomas; Li, Yinyin et al. (2018) Nuclear ARP2/3 drives DNA break clustering for homology-directed repair. Nature 559:61-66
Proto, Jonathan D; Doran, Amanda C; Gusarova, Galina et al. (2018) Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution. Immunity 49:666-677.e6
Hernandez, Celine; Huebener, Peter; Pradere, Jean-Philippe et al. (2018) HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis. J Clin Invest 128:2436-2451

Showing the most recent 10 out of 331 publications